Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia
about
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremiaImproving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin AllergyThrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia.Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois.Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity.Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci.Ceftaroline fosamil: a brief clinical review.Determinants of methicillin-susceptible Staphylococcus aureus native bone and joint infection treatment failure: a retrospective cohort studyClinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Vancomycin revisited - 60 years laterClinical management of Staphylococcus aureus bacteremia: a review.Persistent catheter-related Staphylococcus aureus bacteremia after catheter removal and initiation of antimicrobial therapy.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections.Invasive gram-positive bacterial infection in cancer patients.Evaluation of three rapid diagnostic methods for direct identification of microorganisms in positive blood culturesNonculture techniques for the detection of bacteremia and fungemia.Rapid and accurate identification of human-associated staphylococci by use of multiplex PCR.Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?Direct Identification of Staphylococcus aureus and Determination of Methicillin Susceptibility From Positive Blood-Culture Bottles in a Bact/ALERT System Using Binax Now S. aureus and PBP2a TestsClinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia.Staph ID/R: a rapid method for determining staphylococcus species identity and detecting the mecA gene directly from positive blood culture.Predictors of mortality in Staphylococcus aureus BacteremiaTreatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections.Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort studyThe Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearanceRapid Diagnosis of Staphylococcal Catheter-Related Bacteraemia in Direct Blood Samples by Real-Time PCR.Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants.Impact of inappropriate empiric antimicrobial therapy on mortality of septic patients with bacteremia: a retrospective studyTeicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores.Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on OutcomeComparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections?Controlled multicenter evaluation of a bacteriophage-based method for rapid detection of Staphylococcus aureus in positive blood cultures.Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.A current perspective on daptomycin for the clinical microbiologist.Implementation of an Infectious Disease Fellow-Managed Penicillin Allergy Skin Testing Service.A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures.
P2860
Q21261829-219EC18B-7B41-4295-BB22-173A56705DFDQ26779453-6B1FC021-369E-4D66-9DE8-9F559BB566BBQ33437851-8FF8CA35-EE99-4AC6-9B55-819BDE372880Q33483064-2A94CD41-6F86-4805-8685-A200D1118DD4Q33700986-2ACA5A10-FB1C-457E-8301-304528F8A677Q33704733-3FD95FE9-36E7-4B6C-A48D-12E9A5D3EEB1Q33939080-8610761B-7D7E-4602-8466-39078E87DB3DQ34100226-066DCB5E-6E6A-4FC2-9CC4-3DF955581CC2Q34157657-FB7B5E37-E14D-477A-948C-7076625A40B5Q34433066-CDA8F3CF-5914-4DBE-954E-49C4E3EAEF73Q34441035-B6F34AF3-DF3A-4445-BABB-60DD31220212Q34463444-FD0F604E-704C-4103-AB34-EB3A140C0F5AQ34478074-116B62DA-8EED-49F3-922A-34AED97090A2Q34737617-7340A1EE-6CF8-4CB3-AC03-0F70360F8C0FQ34999884-24C10733-406F-4E37-BBE1-CFDB652197A7Q35165032-ACF64FE5-0A17-4F1B-AB89-A336F4114DA4Q35165426-97E0ED20-DFED-40BF-A0D8-55EF42623327Q35273313-B2984359-2DAD-4F06-B944-CFA6111242A5Q35364152-18C1D721-0BDE-4FDE-A72D-11DD5DC04065Q35657369-8809A0DC-38B1-42EC-B8D6-AE00F2BC0EA0Q35668314-58260EE6-82D4-4DFA-A324-137ACAFE6AFDQ35806865-490EFA84-5CCE-4D03-9ED2-261D46CA0813Q35940556-A62720C0-DDE7-41E5-91D6-D2383A3B07DDQ35960730-334110AE-F47B-4369-A8A1-6242BFEAEF85Q36026942-8479AAD2-2BA9-4227-964E-5C5C7818D4B7Q36082891-D3893762-4BB3-4D19-954C-A28039BFDAD8Q36089167-32D91712-81DF-48DC-B4EC-C1C6A4AA08D5Q36115773-983D2748-D996-4672-8D63-6CC7B4D824ABQ36157258-40BDAC82-6B48-40DD-9A9B-121683DA9D4BQ36165152-623CF102-8B1F-4BB7-8705-AD3CA985CC87Q36181397-58273289-DC1D-4DE8-9622-51ABA0356322Q36558322-0AD1640B-4AE6-4816-9AF7-C863A83A1CA8Q36576652-2F7CD69B-6B2C-4246-8644-FFF84699AC74Q36836505-42D6878D-B310-4F98-B147-4DC7628E7683Q36856946-7F7622E5-85C3-4C42-9C60-2C300EEF807BQ36884496-BB6FB0FC-F565-442B-A003-6F6CA3463674Q36972978-BDE9B4D2-C6D4-4307-ACFA-C01741D60C50Q37263289-4A66BA4B-719E-478A-B863-737629DF9B1BQ37305626-FD759CB9-0AE0-4144-A576-9FA64C703C1AQ37444795-07827345-022E-406B-A64A-388DA3C1F5DB
P2860
Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia
@ast
Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia
@en
type
label
Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia
@ast
Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia
@en
prefLabel
Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia
@ast
Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia
@en
P2093
P2860
P356
P1476
Outcome of vancomycin treatmen ...... aphylococcus aureus bacteremia
@en
P2093
Eui-Chong Kim
Kang-Won Choe
Kye-Hyung Kim
Nam-Joong Kim
Sung-Han Kim
P2860
P304
P356
10.1128/AAC.00700-07
P407
P577
2007-11-05T00:00:00Z